HCA vs. DLB
HCA (HCA Healthcare, Inc.) and DLB (Dolby Laboratories, Inc.) are both stocks. HCA operates in Medical Care Facilities (Healthcare), while DLB operates in Information Technology Services (Technology). Over the past 10 years, HCA returned 18.27%/yr vs 2.40%/yr for DLB. At a 0.31 correlation, their price movements are largely independent.
Performance
HCA vs. DLB - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with HCA having a -16.94% return and DLB slightly lower at -17.26%. Over the past 10 years, HCA has outperformed DLB with an annualized return of 18.27%, while DLB has yielded a comparatively lower 2.40% annualized return.
HCA
- 1D
- 2.29%
- 1M
- -9.44%
- YTD
- -16.94%
- 6M
- -19.89%
- 1Y
- 4.87%
- 3Y*
- 12.30%
- 5Y*
- 13.79%
- 10Y*
- 18.27%
DLB
- 1D
- -0.40%
- 1M
- -3.24%
- YTD
- -17.26%
- 6M
- -21.32%
- 1Y
- -28.66%
- 3Y*
- -13.16%
- 5Y*
- -10.74%
- 10Y*
- 2.40%
HCA vs. DLB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HCA HCA Healthcare, Inc. | -16.94% | 56.71% | 11.75% | 13.83% | -5.64% | 57.58% | 12.07% | 20.24% | 43.37% | 18.67% |
DLB Dolby Laboratories, Inc. | -17.26% | -16.27% | -7.95% | 23.82% | -24.90% | -0.99% | 42.99% | 12.63% | 0.78% | 38.73% |
Correlation
The correlation between HCA and DLB is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Mar 10, 2011 | 0.31 |
Over the past year, the correlation between HCA and DLB has dropped to 0.01 - well below their long-term average of 0.31, suggesting their price drivers have been diverging.
Fundamentals
HCA:
$28.46
DLB:
$2.53
HCA:
13.60
DLB:
20.79
HCA:
1.62
DLB:
30.68
HCA:
1.22
DLB:
3.71
HCA:
$75.60B
DLB:
$1.36B
HCA:
$31.37B
DLB:
$1.19B
HCA:
$15.60B
DLB:
$347.35M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HCA vs. DLB — Risk / Return Rank
HCA
DLB
HCA vs. DLB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for HCA Healthcare, Inc. (HCA) and Dolby Laboratories, Inc. (DLB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HCA | DLB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.32 | ||
| Sortino ratioReturn per unit of downside risk | +1.95 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 0.80 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 0.15 | -0.96 | +1.10 |
| Martin ratioReturn relative to average drawdown | 0.44 | -1.93 | +2.37 |
Loading charts...
Drawdowns
HCA vs. DLB - Drawdown Comparison
The maximum HCA drawdown since its inception was -54.74%, smaller than the maximum DLB drawdown of -62.19%. Use the drawdown chart below to compare losses from any high point for HCA and DLB.
Loading charts...
Drawdown Indicators
| HCA | DLB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.74% | -62.19% | +7.45% |
Max Drawdown (1Y)Largest decline over 1 year | -33.62% | -30.11% | -3.51% |
Max Drawdown (3Y)Largest decline over 3 years | -33.62% | -38.92% | +5.30% |
Max Drawdown (5Y)Largest decline over 5 years | -39.49% | -44.41% | +4.92% |
Max Drawdown (10Y)Largest decline over 10 years | -54.74% | -45.04% | -9.70% |
Current DrawdownCurrent decline from peak | -28.87% | -45.04% | +16.17% |
Average DrawdownAverage peak-to-trough decline | -11.04% | -22.37% | +11.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.15% | 14.84% | -3.69% |
Volatility
HCA vs. DLB - Volatility Comparison
HCA Healthcare, Inc. (HCA) has a higher volatility of 8.97% compared to Dolby Laboratories, Inc. (DLB) at 6.02%. This indicates that HCA's price experiences larger fluctuations and is considered to be riskier than DLB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HCA | DLB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.97% | 6.02% | +2.95% |
Volatility (6M)Calculated over the trailing 6-month period | 21.53% | 20.37% | +1.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.33% | 25.14% | +2.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.90% | 25.03% | +4.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.63% | 26.61% | +6.02% |
Dividends
HCA vs. DLB - Dividend Comparison
HCA's dividend yield for the trailing twelve months is around 0.76%, less than DLB's 2.68% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DLB Dolby Laboratories, Inc. | 2.68% | 2.10% | 1.57% | 1.29% | 1.45% | 0.96% | 0.91% | 1.15% | 1.08% | 0.94% | 1.11% | 1.25% |
HCA HCA Healthcare, Inc. | 0.76% | 0.62% | 0.88% | 0.89% | 0.93% | 0.75% | 0.63% | 1.08% | 1.12% | 0.00% | 0.00% | 0.00% |
Financials
HCA vs. DLB - Financials Comparison
This section allows you to compare key financial metrics between HCA Healthcare, Inc. and Dolby Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HCA vs. DLB - Profitability Comparison
HCA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a gross profit of 8.18B and revenue of 19.51B. Therefore, the gross margin over that period was 41.9%.
DLB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dolby Laboratories, Inc. reported a gross profit of 350.90M and revenue of 395.63M. Therefore, the gross margin over that period was 88.7%.
HCA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported an operating income of 3.18B and revenue of 19.51B, resulting in an operating margin of 16.3%.
DLB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dolby Laboratories, Inc. reported an operating income of 112.95M and revenue of 395.63M, resulting in an operating margin of 28.6%.
HCA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a net income of 1.88B and revenue of 19.51B, resulting in a net margin of 9.6%.
DLB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dolby Laboratories, Inc. reported a net income of 94.92M and revenue of 395.63M, resulting in a net margin of 24.0%.
Frequently Asked Questions
HCA and DLB have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HCA has higher volatility (8.97%) compared to DLB (6.02%). In terms of maximum drawdown, HCA dropped -54.74% vs DLB's -62.19%.
HCA currently has the higher Sharpe Ratio (0.18 vs -1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HCA and DLB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer